Search Results - cell-reprogramming

1 Results

Sort By:

Method for Generating Pluripotent and Multipotent Cells

Abstract: Research and clinical applications of induced pluripotent stem (iPS) cells are currently limited by reprogramming methods that may modify the host genome, and therefore be potentially unsafe and problematic for use in basic research, cell-based therapies, and drug-discovery applications. Researchers at the National Cancer Institute’s Laboratory...

Published: 4/8/2024 | Inventor(s): David Roberts, Sukhbir Kaur, Jeff Isenberg

Keywords(s): cell-based therapies, cell-reprogramming, iPS cells

Category(s): TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, Application > Research Materials